CD8A and neoplasm: As expected, therapy response was associated with cytotoxic immune cells such as CD8+ T cells in tumor and tdLNs, and NK cells in tdLNs, both of which are known for their potent anti-tumor immunity and have also been described to display memory-like responses once matured [40,41].